Operative outcomes in mitral valve surgery: Combined effect of surgeon and hospital volume in a population-based analysis  by Kilic, Arman et al.
A
C
D
Acquired Cardiovascular Disease Kilic et alOperative outcomes in mitral valve surgery: Combined effect
of surgeon and hospital volume in a population-based analysisArman Kilic, MD,a Ashish S. Shah, MD,a John V. Conte, MD,a William A. Baumgartner, MD,a and
David D. Yuh, MDbFrom th
ical I
Surge
This stu
Johns
Disclosu
Receive
for pu
Address
Surge
Have
0022-52
Copyrig
http://dx
638Objective: We evaluated the combined effect of hospital and surgeon volume on operative outcomes of mitral
valve surgery in the United States.
Methods: The Nationwide Inpatient Sample was used to identify adult patients undergoing isolated mitral valve
surgery for mitral regurgitation from 2003 to 2008. Hospitals and surgeons were separately stratified into equal-
size tertiles according to annual overall mitral valve operative volumes. Multivariate logistic regression analysis
was conducted, adjusting for multiple patient, hospital, and operative data, to determine the separate and com-
bined effects of hospital and surgeon volume on operative outcomes.
Results: A total of 50,152 eligible patients were identified during the study period. Although both hospital and
surgeon volume correlated significantly with operative mortality in separate risk-adjusted analyses, only lower
surgeon volume persisted as a significant risk factor in the combined risk-adjusted analysis. Moreover, although
hospital volume only accounted for 10.7% of the surgeon volume effect on increased mortality for low-volume
surgeons, surgeon volume accounted for 74.5% of the hospital volume effect on increased mortality in low-
volume hospitals. Surgeon, but not hospital, volume correlated with inpatient costs. Also, significant trends
were seen with repair rates, with increasing surgeon volume demonstrating a relatively stronger correlation
with the odds of repair (P<.001) than hospital volume (P ¼ .01).
Conclusions: The effect of hospital volume on operative outcomes of mitral valve surgery was largely driven by
the individual surgeon volumes within that hospital. Conversely, surgeon volume affected these outcomes inde-
pendently of hospital volume. Identifying the processes by which higher volume surgeons attain better outcomes
in mitral valve surgery would therefore be prudent. (J Thorac Cardiovasc Surg 2013;146:638-46)Procedural volume is increasingly being recognized as an im-
portant contributor to operative outcomes. This has led the
Leapfrog Group (Washington, DC) to adopt evidence-based
hospital referral as a part of its safety standards to reduce na-
tionwide mortality for several elective procedures, including
cardiovascular procedures, such as coronary artery bypass
grafting, percutaneous coronary interventions, aortic valve re-
placement, and abdominal aortic aneurysm repair.1 In several
of the studies that have helped form the basis for these stan-
dards, either hospital volumeor surgeonvolumewas examined
separately, rather than being evaluated together in a combined
analysis.2-5 This is a shortcoming, because it is unclear towhat
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The Journal of Thoracic and Cardiovascular Surgthat operative outcomes would be different in 2 hospitals
with the same composite volume, with 1 having 100
surgeons each performing 5 procedures annually, and the
other having 5 surgeons each performing 100 of the same
procedures annually. Similarly, it is unclear whether hospital
volume would modify the outcomes of a high- versus low-
volume surgeon to a different degree.
Similar to the other major cardiovascular procedures
noted, the effect of either hospital or surgeon volume on op-
erative outcomes in mitral valve surgery has been studied
separately. The aim of the present study was to conduct
a population-based analysis to evaluate the combined effect
of hospital and surgeon volume on operative outcomes after
mitral valve surgery in the United States.PATIENTS AND METHODS
Data Source
We used the Agency for Healthcare Research and Quality Healthcare
Cost and Utilization Project – Nationwide Inpatient Sample (NIS) data
set, which is the largest all-payer inpatient database in the United States.
Moreover, the NIS database contains patient-level hospital discharge
data from 1050 hospitals in 44 states in the United States, approximating
a 20% stratified sample of hospitals.6 After weighting, these data reflect
about 95% of all hospital discharges in the United States. The database
does not contain any identifiable patient information and is a publically
available registry. The institutional review board therefore granted our
study exempt status.ery c September 2013
Abbreviations and Acronyms
ICD-9 ¼ International Classification of Diseases,
Ninth Revision
NIS ¼ Nationwide Inpatient Sample
STS ¼ Society of Thoracic Surgeons
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DStudy Design
The present study was a retrospective study limited to adult (age  18
years) patients undergoing isolated mitral valve surgery for mitral regurgi-
tation as identified in the NIS database from January 2003 to December
2008. The International Classification of Diseases, Ninth Revision
(ICD-9) codes were used to identify eligible patients. Moreover, the
ICD-9 procedure code 35.12 was used to identify mitral valve repairs
and the ICD-9 procedure codes 35.23 and 35.24 were used to identify mi-
tral valve replacement. Mitral regurgitation was identified by the diagnosis
code 424.0. To maintain a homogenous study population and to limit con-
founding, those with mitral stenosis, rheumatic disease, infective endocar-
ditis, or concomitant aortic valve disease were excluded from the analysis
(ICD-9 diagnosis codes 093.21, 394.0, 394.1, 394.2, 396, 396.0, 396.3,
396.8, and 421.0).
Patients undergoing concomitant procedures were also excluded from
the analysis. The ICD-9 codes for concomitant procedures included
35.11 (aortic valve repair), 35.21 or 35.22 (aortic valve replacement),
36.1x (coronary artery bypass grafting), 35.14 (tricuspid valve repair),
and 35.27 or 35.28 (tricuspid valve replacement). Patients undergoing reo-
perative valve surgery were also excluded using the diagnosis code V43.3,
which identifies patients with a previous heart valve prosthesis. For eligible
patients, the primary outcome was operative mortality, defined as in-
hospital mortality occurring during the same admission as the mitral valve
operation. Secondary outcomes included inpatient hospital costs and rates
of mitral valve repair.A
CVolume Categories
The average annual hospital and surgeon volumes were calculated for
all mitral valve operations. Hospitals and surgeons were separately classi-
fied into equal-size tertiles according to hospital and surgeon procedural
volume, respectively. These tertiles were used to define low-, intermedi-
ate-, and high-volume hospitals or surgeons. Raw data plots were also gen-
erated to demonstrate operative outcomes at the individual surgeon or
hospital level across the entire spectrum of volume.
Variables
The patient factors included in the present analysis were age, gender,
race, and comorbidities. The clinical factors included type of mitral valve
operation (ie, repair or replacement) and acuity (ie, elective vs urgent/
emergent). The system factors included payment status (ie, Medicare,
Medicaid, self-pay or privately insured, or other form of payment), teach-
ing status of hospital, geographic location of hospital, hospital volume, and
surgeon volume. The year of operation was also included.Statistical Analysis
Separate risk-adjusted multivariate logistic regression analyses were
conducted to evaluate the separate effects of hospital or surgeon volume
on operative mortality after mitral valve surgery. Because each of the listed
patient, clinical, and system factors had less than 20%missing data, we in-
cluded all of them in these risk-adjusted analyses. Patients with missing
data entries were simply removed from the multivariate model. Logistic re-
gression analysis adjusted for the same variables but including both hospi-
tal and surgeon volume in the model was also conducted to test theThe Journal of Thoracic and Cacombined effect of these factors on operative mortality. Collinearity and
significant interactions were thoroughly tested.
The proportion that surgeon volume contributed to the hospital volume
effect was calculated by the following equation derived from previous pub-
lished studies: (ORHORHS)/(ORH1), where ORH is the odds ratio for
hospital volume in risk-adjusted logistic regression analysis that included
the hospital volume but excluded the surgeon volume, and ORHS is the
odds ratio for hospital volume using the combined analysis that also in-
cluded the surgeon volume.7 Similarly, the proportion that hospital
volume contributed to the surgeon volume effect was calculated as follows:
(ORSORHS)/(ORS1), where ORS is the odds ratio obtained for surgeon
volume in the risk-adjusted analysis that included the surgeon volume but
excluded the hospital volume.
For cost analysis, we collected data on hospital costs rather than charges,
because costs are a better estimation of resource use, and charges tend to
reflect pricing decisions that take into account payer policies and other fac-
tors unrelated to resource usage. Costs were derived from hospital charges
using the cost/charge ratios developed by the Agency for Healthcare Re-
search and Quality using Centers for Medicare and Medicaid Services
data. Similar to operative mortality, cost comparisons and comparisons of
mitral valve repair rates were made between various surgeon and hospital
strata.
In examining the data, we chose to exclude surgeons or hospitals with
an average volume of less than 1 mitral valve operation annually, because
these generally reflect coding errors within administrative databases such
as the NIS, as demonstrated previously.7,8 All data included in the present
study were weighted data, and survey statistics were therefore used for
statistical comparisons. Moreover, we used the adjusted Wald test to
compare continuous variables and a design-based Pearson’s c2 statistic
for categorical data. All analyses were performed with STATA statistical
software, version 11 (StataCorp LP, College Station, Tex).
RESULTS
Study Population
A total of 50,152 eligible patients were identified as un-
dergoing isolated mitral valve surgery for mitral regurgita-
tion during the study period (Table 1). Their mean age
was 61.9  13.7 years, with 16,851 patients (33.6%) aged
70 years or older. The distribution of men (52.7%;
n ¼ 26,430) and women (47.3%; n ¼ 23,722) was roughly
equal. Most operations were performed on an elective basis
(70.6%; n¼ 35,362) and were conducted at teaching hospi-
tals (67.0%; n ¼ 33,602). Also, most were mitral valve
repairs (50.7%; n ¼ 25,427).
Hospital and Surgeon Volume
Themean annual hospitalmitral valvevolumewas 89.4
75.1 cases/y (median, 61).When divided into equal-size ter-
tiles, the thresholds for hospital volume were as follows:
low (1-41 cases/y), intermediate (42-94.5 cases/y), and
high (>94.5 cases/y). For surgeon volume, themean number
of annual mitral valve operations was 22.9  30.5 cases/y
(median, 12 cases/y). The volume ranges for the equal-
size tertiles were low (1-6.5 cases/y), intermediate
(6.6-20.5 cases/y), and high (>20.5 cases/y).
Operative Mortality
The unadjusted operative mortality rate for the entire co-
hort was 3.4%. In stratifying patients according to hospitalrdiovascular Surgery c Volume 146, Number 3 639
TABLE 1. Study population characteristics
Patient characteristic Study population (n ¼ 50,152)
Age (y) 61.9  13.7
Female gender 23,722/50,152 (47.3%)
Race
Caucasian 33,234/41,439 (80.2%)
African American 3771/41,439 (9.1%)
Other 4475/41,439 (10.8%)
Payment
Private insurance or self-pay 23,425/50,054 (46.8%)
Medicare 22,574/50,054 (45.1%)
Medicaid 2603/50,054 (5.2%)
Other 1452/50,054 (2.9%)
Comorbidity
Atrial fibrillation 25,477/50,152 (50.8%)
Coronary artery disease 11,585/50,152 (23.1%)
Myocardial infarction 3109/50,152 (6.2%)
Congestive heart failure 24,524/50,152 (48.9%)
Peripheral vascular disease 1505/50,152 (3.0%)
Cerebrovascular disease 1906/50,152 (3.8%)
COPD 12,488/50,152 (24.9%)
Diabetes mellitus 5166/50,152 (10.3%)
Chronic renal disease 2658/50,152 (5.3%)
Liver disease 201/50,152 (0.4%)
Charlson comorbidity index 1.1  1.2
Admission acuity
Elective 35,362/50,088 (70.6%)
Urgent/emergent 14,726/50,088 (29.4%)
Teaching hospital 33,602/50,152 (67.0%)
Hospital region
Midwest 8426/50,152 (16.8%)
Northeast 14,494/50,152 (28.9%)
South 21,465/50,152 (42.8%)
West 5767/50,152 (11.5%)
Operation type
Mitral valve repair 25,427/50,152 (50.7%)
Mitral valve replacement 24,725/50,152 (49.3%)
Frequency data presented as number (%) and continuous data as mean  standard
deviation. COPD, Chronic obstructive pulmonary disease.
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Dvolume, the unadjusted mortality for mitral valve repair
ranged from 1.1% for high-volume centers to 1.8% for
low-volume centers (P ¼ .20; Figure 1). For replacements,
unadjusted mortality ranged from 4.6% to 5.8% in high-
and low-volume hospitals, respectively (P ¼ .35). With re-
spect to surgeon volume, significant trends were observed,
unlike with hospital volume. Moreover, the operative mor-
tality ranged from 1.0% to 2.7% with repairs (P ¼ .008)
and 3.6% to 7.4% with replacements (P<.001) for high-
and low-volume surgeons, respectively (Figure 1). These
trends were also evident when examining various combina-
tions of surgeon and hospital volume and their effect on
overall mortality rates (Figure 2).
When examined independently of surgeon volume, the
hospital volume significantly affected risk-adjusted mortal-
ity, such that intermediate- and low-volume hospitals had640 The Journal of Thoracic and Cardiovascular Surggreater mortality rates than high-volume centers (Table 2).
Similarly, when examined independently of hospital vol-
ume, increasing surgeon volumewas associated with signif-
icantly reduced risk-adjusted mortality. However, when
both hospital and surgeon volume were included in
the same risk-adjusted multivariate model, only low- and
intermediate-volume surgeons were found to have a signifi-
cantly increased risk of operative mortality. Low-volume
surgeons had more than a twofold increase in risk-adjusted
mortality compared with high-volume surgeons in the com-
bined analysis (OR, 2.10;P<.001; Table 2). Similarly, when
the raw data were graphically plotted, a stronger decreasing
trend in mortality was identified with increasing surgeon
versus increasing hospital volume (Figure 3). This raw
data plot also demonstrated that a cluster of lower volume
surgeons and hospitals had attained acceptable outcomes, al-
though, as a whole, lower volume surgeons or centers had
greater mortality rates than higher volume providers.
Relative Contributions of Hospital and Surgeon
Volume to Operative Mortality
Using the formulas described in the ‘‘Methods’’ section,
surgeon volume accounted for 41.8% and 74.5% of the
greater operative mortality risk seen in the intermediate-
and low-volume hospitals, respectively (Figure 4). Thus, sur-
geonvolumewas responsible for 10% of the 14% increase in
risk-adjusted mortality seen in low-volume hospitals and for
13% of the 32% increase in intermediate-volume hospitals.
Conversely, hospital volume only accounted for 16.0%
and 10.7% of the increased mortality seen in intermediate-
and low-volume surgeons, respectively (Figure 4). This trans-
lated into hospital volume only being responsible for 12% of
the 110% increase in risk-adjusted mortality observed with
low-volume surgeons and 7% of the 42% increase for
intermediate-volume surgeons.
Repair Rates
Significant trends were found in the rates of mitral valve
repair across hospital and surgeon volume strata. Use of
mitral valve repair ranged from 43.8% in low-volume hos-
pitals to 56.9% in high-volume hospitals (P ¼ .01). These
trends in repair rates were even stronger with surgeon vol-
ume, ranging from 41.7% to 59.1% for low- and high-
volume surgeons, respectively (P< .001). After plotting
the raw data, it was clear that increasing surgeon volume
had a stronger correlation with increasing rates of repair,
although hospital volume also had a significant association
(Figure 5).
Hospital Costs
Hospital volume was not found to significantly affect
inpatient costs within any of the surgeon volume strata
(Figure 6). Conversely, surgeon volume had a significant
effect on inpatient costs across all hospital volume strata,ery c September 2013
FIGURE 1. Trends in operative mortality, stratified by surgeon and hospital volume and mitral valve repair versus replacement. *P value<.05 for trend in
decreasing mortality with increasing volume.
Kilic et al Acquired Cardiovascular Diseasewith low-volume surgeons consistently having the greatest
associated hospital costs (each, P<.05).A
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DDISCUSSION
The surgical management of mitral valve disease has
evolved significantly during the past decade. Moreover,
mitral valve repair has become the preferred option over
replacement because of the improved survival and av-
oidance of anticoagulation.9-12 Furthermore, the overall
number of mitral valve operations on a national level is
thought to be increasing owing to the aging population in
conjunction with expected increases in the prevalence of
cardiovascular disease.13 With these ongoing nationwide
changes, an analysis of factors that contribute to outcomes
in a modern cohort of patients is prudent.FIGURE 2. Operative mortality for various combinations of surgeon and
hospital volume.Use of NIS Registry
Recently, attention has shifted to nonpatient factors that
might influence operative mortality in high-risk surgery,
such as hospital teaching status, hospital procedural volume,
surgeon age, surgeon specialty, and surgeon procedural vol-
ume.2-5,7,8,14-19 In the present study, we used the NIS
database to examine the effect of hospital and surgeon
volume on operative mortality in mitral valve surgery. We
chose to use this registry for several reasons. Foremost,
the NIS is the largest all-payer database in the United States
and therefore can provide a ‘‘real-world snapshot’’ of inpa-
tient outcomes that other multicenter registries are unable
to provide. Furthermore, because the NIS is a mandated reg-
istry, the effect of reporting bias is reduced. The effect of re-
porting biases in clinical registries such as the Society
of Thoracic Surgeons (STS) database is unknown. A recentThe Journal of Thoracic and Castudy of lung cancer resection, for instance, demonstrated
that the STS national database represented only a small
percentage of lung resections performed nationally (as
determined by the NIS database) and tended to report signif-
icantly lower mortality rates than the national results.20 This
questions the broad generalizability of clinical registries that
have select reporting. Finally, we believe our use of the NIS
databasewas supported by themultitude of high-quality and
high-impact volume–outcomes analyses that have been per-
formed using this registry.5,7,21,22Study Findings
The principal finding of our analysis was that surgeon
volume affects operative mortality, irrespective of hospital
volume, and the effect of hospital volume on operative mor-
tality is dependent on the individual surgeon volumes
within that hospital. We also found parallel trends with in-
patient costs of care, with low-volume surgeons havingrdiovascular Surgery c Volume 146, Number 3 641
TABLE 2. Univariate and multivariate logistic regression analysis evaluating effect of hospital and/or surgeon volume on operative mortality
Covariate
Univariate analysis Multivariate analysis
OR (95% CI) P value OR (95% CI) P value
Hospital volume (no surgeon volume)
High Reference Reference
Intermediate 1.45 (1.01-2.07) .04 1.55 (1.05-2.29) .03
Low 1.57 (1.14-2.16) .006 1.55 (1.02-2.35) .04
Surgeon volume (no hospital volume)
High Reference Reference
Intermediate 1.48 (1.05-2.07) .02 1.50 (1.07-2.11) .02
Low 2.73 (1.95-3.82) <.001 2.22 (1.53-3.23) <.001
Hospital volume (with surgeon volume)
High Reference Reference
Intermediate 1.45 (1.01-2.07) .04 1.32 (0.91-1.91) .15
Low 1.57 (1.14-2.16) .006 1.14 (0.75-1.75) .54
Surgeon volume (with hospital volume)
High Reference Reference
Intermediate 1.48 (1.05-2.07) .02 1.42 (1.00-2.02) .05
Low 2.73 (1.95-3.82) <.001 2.10 (1.41-3.13) <.001
Age (increasing) 1.06 (1.05-1.07) <.001 1.04 (1.03-1.06) <.001
Female gender 1.55 (1.25-1.92) <.001 1.18 (0.92-1.51) .20
Race
Caucasian Reference Reference
African American 1.20 (0.82-1.75) .35 0.88 (0.56-1.39) .58
Other 1.20 (0.80-1.78) .38 1.16 (0.74-1.82) .51
Payment status
Private or self-pay Reference Reference
Medicare 5.01 (3.72-6.74) <.001 1.92 (1.24-2.95) .003
Medicaid 3.18 (1.83-5.51) <.001 2.19 (1.30-3.71) .004
Other 1.31 (0.45-3.87) .62 0.76 (0.21-2.74) .68
Comorbidity
Atrial fibrillation 0.83 (0.64-1.07) .15 0.54 (0.40-0.72) <.001
Coronary artery disease 1.73 (1.34-2.23) <.001 0.74 (0.49-1.12) .16
Myocardial infarction 3.35 (2.34-4.78) <.001 2.41 (1.40-4.14) .002
Congestive heart failure 2.98 (2.26-3.93) <.001 1.46 (1.07-1.99) .02
Peripheral vascular disease 2.84 (1.84-4.37) <.001 1.99 (1.21-3.25) .007
Cerebrovascular disease 2.03 (1.29-3.20) .002 1.42 (0.76-2.65) .27
COPD 1.18 (0.91-1.54) .20 0.93 (0.70-1.24) .63
Diabetes mellitus 0.89 (0.61-1.31) .56 0.56 (0.35-0.92) .02
Chronic renal disease 2.37 (2.03-2.75) <.001 2.05 (1.73-2.43) <.001
Liver disease 6.34 (2.83-14.2) <.001 4.84 (2.09-11.2) <.001
Urgent or emergent surgery 3.41 (2.68-4.34) <.001 2.01 (1.53-2.64) <.001
Nonteaching hospital 1.15 (0.88-1.50) .32 0.90 (0.63-1.27) .53
Hospital region
Midwest Reference Reference
Northeast 1.47 (0.91-2.37) .12 1.39 (0.75-2.59) .30
South 1.75 (1.11-2.75) .02 1.35 (0.74-2.45) .32
West 1.12 (0.67-1.90) .66 0.96 (0.49-1.89) .90
Mitral valve replacement 3.55 (2.72-4.65) <.001 2.12 (1.56-2.89) <.001
OR, Odds ratio; CI, confidence interval; COPD, chronic obstructive pulmonary disease.
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Dgreater costs across all hospital volume strata. Finally, we
found significant differences in the rate of mitral valve re-
pair use across surgeon volume and hospital volume strata.
These differences in repair rates were more pronounced
across the spectrum of surgeon volume than hospital vol-
ume, although the latter also demonstrated a significant642 The Journal of Thoracic and Cardiovascular Surgcorrelation. Although the overall repair rates for the entire
study cohort were lower than those reported by studies us-
ing the STS database, we believe these differences likely re-
flect that STS-participating surgeons and hospitals have
greater rates of repair than nonparticipating providers,
which would tend to overestimate the real-world repairery c September 2013
FIGURE 3. Operative mortality rates examined at (A) individual surgeon
or (B) center level.
FIGURE 5. Mitral valve repair rates examined at (A) individual surgeon
or (B) center level.
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Drate, which is better judged using NIS data. In addition,
these STS studies had different patient populations than
ours, with 1 in particular excluding emergency operations,FIGURE 4. Relative contributions of hospital and surgeon volume to in-
creased operative mortality risk for lower volume centers and surgeons.
The Journal of Thoracic and Cawhich would be expected to increase the proportion of re-
pairs in their study cohort.9Implications
There are several potential implications of our data. One
recommendation based on these data might be that mitral
valve operations should be preferentially performed by sur-
geons with high mitral volumes. Although national opera-
tive mortality rates might be reduced with such a policy, it
is important to note that many low-volume surgeons attain
excellent outcomes. As demonstrated in Figure 3, a signifi-
cant cluster of surgeons with low annual volumes also had
low operative mortality. Therefore, our data are not meant
to impugn all low-volume surgeons, because some certainly
have outcomes comparable to those of higher volume sur-
geons. There might also be a positive effect for a lower vol-
ume in that experienced surgeons with smaller practices
might have more time to care for each patient, which could
optimize results. Additionally, in clinical practice, low-
volume surgeons who were earlier in their career tend to
have a greater percentage of emergency cases, many ofrdiovascular Surgery c Volume 146, Number 3 643
FIGURE 6. Trends in inpatient hospital costs stratified by various (A)
hospital and (B) surgeon volume combinations. *P<.05.
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Dwhich are performed on the weekend. This could have
contributed to these varying outcomes, although we did
perform a risk adjustment for elective versus emergency op-
erations in our multivariate model.
Related to this concept is that our analysis was not de-
signed to identify causal relationships, merely associative
ones. Therefore, we cannot state for certain that volume
drives outcomes. It might be that surgeons who have excel-
lent outcomes do so from an early stage in their career.
As their reputation and referral base grows, these well-
performing surgeons likely have significant increases in
their annual operative volumes. Therefore, it might be that
outcomes drive volume to a certain degree.
Despite this, our data have shown that at a national level,
higher surgeon volume correlates with greater rates of
repair and improved outcomes. Furthermore, this relation-
ship exists largely irrespective of hospital volume. It might,
therefore, be prudent to identify the specific processes by
which higher volume surgeons attain better results and at-
tempt to translate these processes to poorly performing
low-volume surgeons. It could be that surgical qualities
such as clinical judgment and technical expertise largely
account for these volume–outcomes relationships, in which
case, experience will be the answer to improving outcomes.
However, other, more specific, processes of care could also
be important. For instance, reviewing a surgeon’s adherence
to clinical guidelines or proven quality metrics might644 The Journal of Thoracic and Cardiovascular Surgidentify divergent practices that can be addressed for im-
provement in outcomes. One such divergent practice could
be repair rates, which we identified as being significantly
different between surgeon volume cohorts. Education
and adoption of repair enabling techniques and technology
will undoubtedly be important measures to improve these
repair rates among lower volume surgeons.
Our finding of surgeon volume affecting outcomes to
a greater degree than hospital volume does have intuitive
validity. Moreover, mitral valve operations are technically
challenging; therefore, it would be expected that a surgeon’s
previous operative experience would play an important role
in outcomes. As supported by previous data, there is likely
a spectrum of procedures for which hospital and surgeon
volume contribute different proportions to surgical mortal-
ity risk according to the nature of the procedure and its as-
sociated postoperative care.7 For instance, esophagectomy,
although technically demanding, also entail a large compo-
nent of postoperative care. In such cases, hospital volume
might affect outcomes to an equal or greater extent than sur-
geon volume. On the other end of the spectrum, for patients
undergoing carotid endarterectomy, who are discharged the
following day, technical expertise would seem to play
a larger role than the postoperative care component. In
such cases, surgeon volume would be expected to influence
operative outcomes to a greater degree than hospital
volume.
Previous Studies of Surgeon or Hospital Volume in
Mitral Valve Surgery
Only a few reports have examined the volume–outcomes
relationship in mitral valve surgery. One such study used the
STS database and analyzed more than 13,000 patients
undergoing elective surgery for mitral regurgitation
between 2000 and 2003.18 Hospitals with higher procedural
volumes were found to have reduced risk-adjusted operative
mortality, increased rates of mitral valve repair, and greater
rates of bioprosthetic use for older patients.18 However, that
analysis did not incorporate individual surgeon volume.
Another study also used the STS database in a more modern
cohort (2005-2007) and found that of the 28,507 patients
undergoing isolated mitral valve surgery, higher surgeon
volume correlated with a greater probability of repair.19 In
that analysis, hospital volume was not analyzed concur-
rently with surgeon volume.
We believe our findings add to the knowledge of the
volume–outcomes relationship in mitral valve surgery by
demonstrating that surgeon volume affects outcomes across
all hospital strata but that the effect of hospital volume is
significantly driven by the individual surgeon volumes
within that hospital. By incorporating both surgeon and hos-
pital volume into our analyses, we believe our study is
unique to the mitral valve data. Moreover, when analyzing
either hospital or surgeon volume, but not both, theery c September 2013
Kilic et al Acquired Cardiovascular Diseaseimportance of these variables can be skewed by not taking
the other into account.Inpatient Costs of Care
With regard to the hospital costs associatedwith themitral
valve procedure, we found trends similar to those observed
with mortality. This also has intuitive validity, because
patients who do not survive to discharge tend to have oper-
ative complications that can result in more complex postop-
erative management, longer intensive care unit stays, and
repeat procedures that exponentially increase the cost of
care. Therefore, it is not unexpected that surgeon volume,
which correlated strongly with operative mortality, also cor-
related strongly with inpatient costs.A
C
DStudy Limitations
Our study had several limitations. Some of these were
related to the NIS database. For instance, we were unable to
control for thevariables included in the data set.One suchvar-
iable that would be important to include but was not available
was the specific etiology of mitral valve insufficiency. Al-
though we had comorbidity data available (eg, atrial fibrilla-
tion, coronary artery disease), we could not state for certain
that these comorbiditieswere the underlying causes of themi-
tral valve regurgitation. Although it is unlikely that surgeon
and hospital volume would be affected disproportionately
by the unmeasuredvariables inour riskadjustment, a possibil-
ity always exists that the inclusion of additional covariates
would have altered the results. Validation of our data in a clin-
ically driven registry is therefore prudent.
Moreover, errors in entry are inherent to any multicenter
database. We tried to minimize this effect by excluding
cases in which the average annual hospital or surgeon vol-
ume was less than 1 case annually. Missing data were also
inherent in these multi-institutional data sets, although the
variables included in our analyses had less than 20% miss-
ing data. Because the NIS is limited to inpatient outcomes,
we could not conduct a longitudinal analysis to determine
the effect of volume on longer term survival.
Another major limitation was that our study was not
designed to delineate between associative versus causal
relationships. Moreover, it is unclear from our analysis
whether surgeon volume was related to lower operative
mortality because of a ‘‘practice makes perfect’’ phenome-
non or whether technically superior surgeons receive
more referrals because of their better outcomes. Thus, it is
unknown whether surgeon volume drives the lower opera-
tive mortality, or lower operative mortality drives the higher
surgeon volume. We were also unable to include surgeon
experience in years or the surgeons’ overall volume with
cardiac surgical procedures, although these could certainly
affect outcomes. Many surgeons also operate in multiple
hospitals and this could have confounded the results.The Journal of Thoracic and CaCONCLUSIONS
In the present large-cohort analysis ofmore than50,000pa-
tients, we examined the separate and combined effects of hos-
pital and surgeon volume on operative mortality, inpatient
costs, and rates of repair in mitral valve surgery. We found
that lower surgeon volume significantly increased the opera-
tive mortality risk and did so independently of hospital vol-
ume. Conversely, the effect of hospital volume on surgical
mortalitywas largelyexplainedby the surgeonvolume,which
contributed to its effect substantially. Similar trends were ob-
servedwith inpatient costs and rates of repair. These data col-
lectively suggest that identifying the processes by which
higher volume surgeons attain better outcomes inmitral valve
surgery is prudent for improving nationwide outcomes.
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